Viewing Study NCT02545595


Ignite Creation Date: 2025-12-24 @ 1:49 PM
Ignite Modification Date: 2026-02-13 @ 4:35 PM
Study NCT ID: NCT02545595
Status: COMPLETED
Last Update Posted: 2016-10-12
First Post: 2013-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sugammadex Dosage Based on Ideal Body Weight for Profound Rocuronium-induced Neuromuscular Blockade Reversal in Morbidly Obese Patients
Sponsor: Poitiers University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module